References
- Jain KK . From molecular diagnostics to personalized medicine. Meet. Rep.2(4), 299–301 (2002).
- Simmons LA , DinanMA , RobinsonTJ , SnydermanR. Personalized medicine is more than genomic medicine: confusion over terminology impedes progress towards personalized healthcare. Per. Med.9(1), 85–91 (2012).
- Nardini C , OsmaniV , CormioPGet al. The evolution of personalised healthcare and the pivotal role of European Regions in its implementation. Futur. Med.18(3), 283–294 (2021).
- Ginsburg GS , PhillipsKA. Precision medicine: from science to value. Health Aff.37(5), 694–701 (2018).
- Sabatini LM , MatthewsC , PtakDet al. Genomic sequencing procedure microcosting analysis and health economic cost-impact analysis: a report of the Association for Molecular Pathology. J. Mol. Diagnostics18(3), 319–328 (2016).
- Seyhan AA , CariniC. Are innovation and new technologies in precision medicine paving a new era in patients centric care?J. Transl. Med.17(1), 1–28 (2019).
- BBC Research . DNA sequencing applications. In: DNA Sequencing: Emerging Technologies and Applications (2016). www.bccresearch.com/market-research/biotechnology/dna-sequencing-emerging-tech-applications-report-bio045f.html
- Cheng CM . On ‘EU-China – a strategic outlook’. Tamkang J. Int. Aff.22(4), 145–152 (2019).
- European Union . Consolidated version of the treaty on the functioning of the European Union. Off. J. Eur. Union326, 344 (2012).
- European Commission . Roadmap for EU-Brazil S & T cooperation. Eur. Comm.October, 1–23 (2018).
- Grimpe C . Erawatch country reports 2012: Denmark (2013). http://erawatch.jrc.ec.europa.eu/erawatch/export/sites/default/galleries/generic_files/file_0366.pdf
- Cyranoski D . China embraces precision therapy. Nature529(7584), 9–10 (2016).
- Kazmierczak M , RittersonR , GardnerD , RosenDH , HanemannT , CasagrandeR. China’s biotechnology development: the role of US and other foreign engagement (2019). www.uscc.gov/sites/default/files/Research/US-China%20Biotech%20Report.pdf
- Vicente AM , BallensiefenW , JönssonJI. How personalised medicine will transform healthcare by 2030: the ICPerMed vision. J. Transl. Med.18(1), 1–4 (2020).
- International Consortium for Personalised Medicine . The ICPerMed vision for 2030. 28 (2019). www.icpermed.eu/media/content/Vision_Paper_2019.pdf
- Auffray C , BallingR , BarrosoIet al. Making sense of big data in health research: towards an EU action plan. Genome Med.8(1), 1–13 (2016).
- D’Errico G , BelloP. KA1 report – Interregional coordination for a fast and deep uptake of personalised medicine – Regions4PerMed (2019). www.regions4permed.eu/wp-content/uploads/2020/07/KA1_Best-Practices.pdf
- Aarestrup FM , AlbeyattiA , ArmitageWJet al. Towards a European health research and innovation cloud (HRIC). Genome Med.12(1), 1–14 (2020).
- European Commission . DG health and food safety. Assessment of the EU Member States’ Rules on Health Data in the Light of GDPR (2019). https://ec.europa.eu/health/sites/default/files/ehealth/docs/ms_rules_health-data_en.pdf
- Germain DP , FouilhouxA , DecramerSet al. Consensus recommendations for diagnosis, management and treatment of Fabry disease in paediatric patients. Clin. Genet.96(2), 107–117 (2019).
- Danieles A . BioXclusters plus paves the way for precision medicine companies to China (2017). www.clustercollaboration.eu/news/bioxclusters-plus-paves-way-precision-medicine-companies-china-market
- Federal Ministry of Education and Research . China strategy 2015–2020 strategic framework for cooperation with China in research, science and education (2015). www.readkong.com/page/china-strategy-2015-2020-strategic-framework-for-8655422
- European Commission . Review of the science and technology cooperation between the European Community and the Government of the People’s Republic of China (2008). http://ec.europa.eu/research/iscp/pdf/china_eu_en.pdf#view=fit&pagemode=none
- Newton Fund . UK-China Research and Innovation Partnership Fund. www.newtonfund.ac.uk/about/about-partnering-Countries/China/
- Bonaccorsi A , FantoniG , ApredaR , GabelloniD. Functional patent classification. Springer Handb. Sci. Technol. Indic.983–1003 (2019).
- Burnette R , SimmonsLA , SnydermanR. Personalized health care as a pathway for the adoption of genomic medicine. J. Pers. Med.2(4), 232–240 (2012).
- Carney SL , HoodL. Leroy Hood expounds the principles, practice and future of systems biology. Drug Discov. Today8(10), 436–438 (2003).
- Jameson LJ , LongoDL. Precision medicine – personalized, problematic, and promising. N. Engl. J. Med.362(5), 567–571 (2011).
- Song CH , HanJW , JeongB , YoonJ. Mapping the patent landscape in the field of personalized medicine. J. Pharm. Innov.12(3), 238–248 (2017).
- Khoury MJ , IademarcoMF , RileyWT. Precision public health for the era of precision medicine. Am. J. Prev. Med.50(3), 398–401 (2016).
- Ricciardi W , StefaniaB. New challenges of public health: bringing the future of personalised healthcare into focus. Eur. J. Public Health27, 36–39 (2017).
- Lü S , WangQ , LiG , SunS , GuoY , KuangH. The treatment of rheumatoid arthritis using Chinese medicinal plants: from pharmacology to potential molecular mechanisms. J. Ethnopharmacol.176, 177–206 (2015).
- Nimmesgern E , NorstedtI , Draghia-AkliR. Enabling personalized medicine in Europe by the European Commission’s funding activities. Per. Med.14(4), 355–365 (2017).
- ICPerMed Database. www.icpermed.eu/app/login
- Chinese National Innovation Funding Programmes. http://chinainnovationfunding.eu/chinese-national-innovation-funding-programmes/
- Lee J , HamidehD , NebekerC. Qualifying and quantifying the precision medicine rhetoric. BMC Genomics20(1), 1–12 (2019).
- Zhang L , WangH , LiQ , ZhaoMH , ZhanQM. Big data and medical research in China. BMJ360, 1–3 (2018).
- Horgan D , BorischB , RicherEet al. Propelling health care into the twenties. Biomed. Hub.5(2), 1–53 (2020).
- Bikard M , MurrayF , GansJS. Exploring trade-offs in the organization of scientific work: collaboration and scientific reward. Manage. Sci.61(7), 1473–1495 (2015).
- He C , WuJ , ZhangQ. Characterizing research leadership on geographical weighted collaboration network. Scientometrics126, 4005–4037 (2021).
- Basu A , FolandP , HoldridgeG , SheltonRD. China’s rising leadership in science and technology: quantitative and qualitative indicators. Scientometrics117(1), 249–269 (2018).
- Babbar S , KoufterosX , BeharaRS , WongCWY. SCM research leadership: the ranked agents and their networks. Supply Chain Manag.24(6), 821–854 (2019).